Cytovale's IntelliSep® Recognized by Modern Healthcare
Cytovale's IntelliSep® has earned recognition as one of Modern Healthcare's Best in Business for the second consecutive year, showcasing its innovative approach to sepsis care. This noteworthy achievement highlights the profound impact IntelliSep has had in assisting healthcare providers in saving lives in emergency departments.
What Makes IntelliSep Stand Out?
IntelliSep is a state-of-the-art rapid sepsis test designed for emergency department (ED) clinicians. It provides objective measurements of immune dysregulation, which is a significant contributor to the onset of sepsis. By delivering results in approximately eight minutes, it allows for swift risk assessments during triage, accelerating timely care for high-risk patients and minimizing unnecessary treatments for those at lower risk.
Impact on Patient Outcomes
Since its launch, IntelliSep has been utilized in the evaluation of over 70,000 patients across various healthcare systems. Recent studies have demonstrated substantial improvements in clinical outcomes, with hospitals using the test achieving a 39% reduction in sepsis mortality rates. Additionally, they have managed to shorten the average hospital stay for patients diagnosed with sepsis by nearly a full day. Notably, there has been an impressive 80% decline in Code Sepsis alerts associated with the usage of IntelliSep, facilitating a more efficient resource allocation in the ED.
Insights from Medical Professionals
Dr. Christopher Thomas, the Vice President and Chief Quality Officer at a leading health system, noted that in the ED, timely detection of life-threatening conditions like sepsis is crucial. He emphasized that IntelliSep plays a pivotal role in enabling ED teams to swiftly and accurately detect or rule out sepsis, thereby improving patient management during critical moments.
Recognition and Industry Impact
The Best in Business program by Modern Healthcare identifies organizations that are pushing the boundaries of innovation, efficiency, and excellence within the healthcare sector. Recipients are recognized for their ability to make a tangible difference in care delivery and operational effectiveness.
As stated by Dan Peres, President of Modern Healthcare, these organizations exemplify the creativity and progress necessary to enhance healthcare delivery. The impact of their innovation is setting new standards for what is possible in patient care and operational efficiency.
Statements from Cytovale Leadership
Ajay Shah, Co-founder and CEO of Cytovale, remarked that receiving this award signifies a broader acknowledgment of the need for more precise diagnostic approaches for sepsis. IntelliSep was designed to offer rapid and accurate detection of immune dysregulation in the ED, thus facilitating consistent and systematic evaluations of sepsis. With wider adoption across numerous health systems, this recognition underscores the necessity of innovative solutions in enhancing patient care.
IntelliSep®: A Game Changer in Diagnostics
The IntelliSep® test is distinguished as the only FDA-cleared rapid sepsis diagnostic for use in Emergency Departments. By utilizing advanced microfluidics and artificial intelligence technology, it provides clinicians with a sensitive and objective detection tool for sepsis. The test evaluates immune system responses to infection and generates a risk score for sepsis within minutes from a standard blood draw, thereby fostering rapid decision-making in patient care.
About Cytovale
Cytovale is dedicated to enhancing patient care through the development of pioneering detection technologies that focus on immune activation. The company aims to shorten the time from triage to life-saving treatments by providing rapid diagnostics, such as IntelliSep®, for assessing sepsis risk with minimal delay. Based in San Francisco, Cytovale has garnered significant backing from venture capital firms.
Frequently Asked Questions
What is the purpose of IntelliSep®?
IntelliSep® is designed to quickly diagnose sepsis by assessing immune dysregulation, enabling faster treatment options in emergency departments.
How has IntelliSep® improved patient care?
It has significantly reduced sepsis mortality rates, shortened hospital stays, and utilized resources more efficiently by decreasing unnecessary procedures.
Who oversees the Best in Business program?
The program is managed by Modern Healthcare, recognizing organizations that excel in innovation and operational efficiency in healthcare.
What is sepsis and why is it critical to diagnose early?
Sepsis is a life-threatening condition caused by the body’s response to infection. Early diagnosis is crucial to enhance treatment outcomes and reduce mortality rates.
Where can I find more information about Cytovale?
For more details on Cytovale and IntelliSep®, visit their official website to learn about their innovative diagnostic solutions.
